Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Cytosorbents (CTSO) Shares Outstanding (Diluted Average) (2016 - 2026)

Cytosorbents filings provide 9 years of Shares Outstanding (Diluted Average) readings, the most recent being $62.2 million for Q4 2025.

  • On a quarterly basis, Shares Outstanding (Diluted Average) rose 14.32% to $62.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $62.2 million, a 14.32% increase, with the full-year FY2025 number at $62.2 million, up 14.32% from a year prior.
  • Shares Outstanding (Diluted Average) hit $62.2 million in Q4 2025 for Cytosorbents, down from $62.8 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $67.2 million in Q2 2025 to a low of $43.3 million in Q2 2021.
  • Median Shares Outstanding (Diluted Average) over the past 5 years was $44.2 million (2023), compared with a mean of $49.7 million.
  • Biggest five-year swings in Shares Outstanding (Diluted Average): increased 0.39% in 2022 and later rose 24.63% in 2024.
  • Cytosorbents' Shares Outstanding (Diluted Average) stood at $43.4 million in 2021, then increased by 0.49% to $43.6 million in 2022, then rose by 2.49% to $44.7 million in 2023, then rose by 21.9% to $54.4 million in 2024, then grew by 14.32% to $62.2 million in 2025.
  • The last three reported values for Shares Outstanding (Diluted Average) were $62.2 million (Q4 2025), $62.8 million (Q3 2025), and $67.2 million (Q2 2025) per Business Quant data.